CGEN 6-K: Oct 13, 2025 press release furnished as Exhibit 99.1

Rhea-AI Filing Summary

Compugen Ltd. (CGEN) filed a Form 6-K noting it issued a press release on October 13, 2025, which is furnished as Exhibit 99.1. With the exception of the third, fourth, and fifth paragraphs of the press release, the information incorporated by reference in this report is also incorporated into the Company’s Registration Statement on Form F-3 (File No. 333-270985).

The report was signed by Eran Ben Dor, General Counsel, on October 14, 2025.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number 000-30902

COMPUGEN LTD.

(Translation of registrant’s name into English)

26 Harokmim Street

Holon 5885849, Israel

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒  Form 40-F ☐

Compugen Ltd.

On October 13, 2025, Compugen Ltd. (the “Company”) issued a press release (the “Press Release”), a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K and incorporated by reference herein.

With the exception of the third, fourth, and fifth paragraphs of the Press Release, the information incorporated by reference in this Report on Form 6-K is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, File No. 333-270985.

Exhibit Number
Description of Exhibit

99.1 Press Release dated October 13, 2025 – “Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025”

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COMPUGEN LTD.
Date: October 14, 2025	By:	/s/ Eran Ben Dor
		Eran Ben Dor General Counsel

FAQ

What did Compugen (CGEN) file?

Compugen filed a Form 6-K reporting it issued a press release on October 13, 2025.

How is the press release included in the filing?

The press release is furnished as Exhibit 99.1 to the Form 6-K.

Is the 6-K incorporated into Compugen’s F-3?

Yes. With the exception of the third, fourth, and fifth paragraphs of the press release, the information incorporated by reference here is also incorporated into the Form F-3.

What is the Form F-3 file number for Compugen?

The Registration Statement on Form F-3 has file number 333-270985.

When was the report signed and by whom?

It was signed by Eran Ben Dor, General Counsel, on October 14, 2025.

What is Compugen’s principal executive office address?

The address is 26 Harokmim Street, Holon 5885849, Israel.